MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Envista Holdings Corporation Total Inventories 2011-2026 | NVST
Annual Total Inventories Envista Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 241 M | 259 M | 301 M | 264 M | 267 M | 278 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 301 M | 241 M | 268 M |
Quarterly Total Inventories Envista Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 282 M | 261 M | 241 M | 266 M | 264 M | 267 M | 259 M | 279 M | 297 M | 307 M | 301 M | 291 M | - | 280 M | 264 M | 274 M | 312 M | 283 M | 216 M | 216 M | 267 M | 267 M | 278 M | 278 M | 278 M | 278 M | 279 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 312 M | 216 M | 272 M |
Total Inventories of other stocks in the Medical instruments industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
82.3 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
2.05 B | $ 21.07 | 1.81 % | $ 10.7 B | USA |
 |
Becton, Dickinson and Company
BDX
|
3.89 B | $ 202.8 | -1.16 % | $ 58.3 B | USA |
 |
ICU Medical
ICUI
|
585 M | $ 151.86 | 0.14 % | $ 3.7 B | USA |
 |
iRhythm Technologies
IRTC
|
14 M | $ 180.4 | -4.68 % | $ 5.63 B | USA |
 |
Repro Med Systems
KRMD
|
3.48 M | $ 5.67 | -2.41 % | $ 259 M | USA |
 |
Masimo Corporation
MASI
|
459 M | $ 140.04 | 1.54 % | $ 7.46 B | USA |
 |
Merit Medical Systems
MMSI
|
306 M | $ 86.37 | -7.31 % | $ 5.03 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
4.57 M | $ 8.03 | -1.95 % | $ 162 M | USA |
 |
Predictive Oncology
POAI
|
386 K | $ 6.83 | 1.08 % | $ 37.2 M | USA |
 |
AtriCure
ATRC
|
75.3 M | $ 41.66 | -1.76 % | $ 1.96 B | USA |
 |
electroCore
ECOR
|
2.16 M | $ 5.62 | 11.73 % | $ 31 K | USA |
 |
Haemonetics Corporation
HAE
|
365 M | $ 82.2 | -2.19 % | $ 4.14 B | USA |
 |
AngioDynamics
ANGO
|
62 M | $ 9.97 | -0.8 % | $ 407 M | USA |
 |
Harvard Bioscience
HBIO
|
24.7 M | $ 0.64 | -1.79 % | $ 27.1 M | USA |
 |
The Cooper Companies
COO
|
846 M | $ 83.71 | 0.69 % | $ 16.7 B | USA |
 |
LeMaitre Vascular
LMAT
|
19.6 M | $ 84.83 | -0.25 % | $ 1.9 B | USA |
 |
Glaukos Corporation
GKOS
|
42 M | $ 113.09 | -0.93 % | $ 5.48 B | USA |
 |
InfuSystem Holdings
INFU
|
4.82 M | $ 8.61 | -4.01 % | $ 178 M | USA |
 |
Isoray
ISR
|
980 K | - | 0.03 % | $ 108 M | USA |
 |
Nephros
NEPH
|
2.47 M | $ 4.89 | -2.5 % | $ 50.8 M | USA |
 |
Utah Medical Products
UTMD
|
9.58 M | $ 59.83 | 1.87 % | $ 217 M | USA |
 |
Intuitive Surgical
ISRG
|
1.49 B | $ 587.18 | 0.36 % | $ 209 B | USA |
 |
Milestone Scientific
MLSS
|
3.71 M | $ 0.3 | 1.23 % | $ 23.9 M | USA |
 |
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | USA |
 |
OraSure Technologies
OSUR
|
34.2 M | $ 2.63 | -1.13 % | $ 196 M | USA |
 |
Pro-Dex
PDEX
|
22.2 M | $ 41.51 | 0.51 % | $ 136 M | USA |
 |
Pulse Biosciences
PLSE
|
5.82 M | $ 14.63 | -0.61 % | $ 703 M | USA |
 |
Repligen Corporation
RGEN
|
202 M | $ 166.85 | 0.26 % | $ 9.3 M | USA |
 |
ResMed
RMD
|
744 M | $ 252.15 | 0.49 % | $ 36.8 B | USA |
 |
BioLife Solutions
BLFS
|
29 M | $ 24.8 | -0.6 % | $ 1.14 B | USA |
 |
STERIS plc
STE
|
581 M | $ 258.0 | -1.03 % | $ 25.4 B | USA |
 |
Stereotaxis
STXS
|
8.43 M | $ 2.53 | -2.13 % | $ 204 M | USA |
 |
Retractable Technologies
RVP
|
19.2 M | $ 0.76 | -2.53 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
15.7 M | $ 22.06 | -1.96 % | $ 1.08 B | USA |
 |
Teleflex Incorporated
TFX
|
600 M | $ 112.75 | 2.49 % | $ 5.28 B | USA |
 |
West Pharmaceutical Services
WST
|
377 M | $ 275.51 | 0.1 % | $ 20.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
564 M | $ 12.76 | 2.2 % | $ 2.59 B | USA |